These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26883593)

  • 21. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
    Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
    Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule.
    Shifrin Y; Peleg A; Ilan O; Nadler C; Kobi S; Baruch K; Yerushalmi G; Berdichevsky T; Altuvia S; Elgrably-Weiss M; Abe C; Knutton S; Sasakawa C; Ritchie JM; Waldor MK; Rosenshine I
    J Bacteriol; 2008 Jul; 190(14):5063-74. PubMed ID: 18502854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The secreted effector protein EspZ is essential for virulence of rabbit enteropathogenic Escherichia coli.
    Wilbur JS; Byrd W; Ramamurthy S; Ledvina HE; Khirfan K; Riggs MW; Boedeker EC; Vedantam G; Viswanathan VK
    Infect Immun; 2015 Mar; 83(3):1139-49. PubMed ID: 25561713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural analysis of a specialized type III secretion system peptidoglycan-cleaving enzyme.
    Burkinshaw BJ; Deng W; Lameignère E; Wasney GA; Zhu H; Worrall LJ; Finlay BB; Strynadka NC
    J Biol Chem; 2015 Apr; 290(16):10406-17. PubMed ID: 25678709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome.
    Soto E; Espinosa N; Díaz-Guerrero M; Gaytán MO; Puente JL; González-Pedrajo B
    J Bacteriol; 2017 Jan; 199(1):. PubMed ID: 27795324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the NleF effector protein from attaching and effacing bacterial pathogens.
    Echtenkamp F; Deng W; Wickham ME; Vazquez A; Puente JL; Thanabalasuriar A; Gruenheid S; Finlay BB; Hardwidge PR
    FEMS Microbiol Lett; 2008 Apr; 281(1):98-107. PubMed ID: 18279332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors.
    Ruchaud-Sparagano MH; Mühlen S; Dean P; Kenny B
    PLoS Pathog; 2011 Dec; 7(12):e1002414. PubMed ID: 22144899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type Three Secretion System in Attaching and Effacing Pathogens.
    Gaytán MO; Martínez-Santos VI; Soto E; González-Pedrajo B
    Front Cell Infect Microbiol; 2016; 6():129. PubMed ID: 27818950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.
    Hemrajani C; Berger CN; Robinson KS; Marchès O; Mousnier A; Frankel G
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3129-34. PubMed ID: 20133763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.
    Pearson JS; Giogha C; Mühlen S; Nachbur U; Pham CL; Zhang Y; Hildebrand JM; Oates CV; Lung TW; Ingle D; Dagley LF; Bankovacki A; Petrie EJ; Schroeder GN; Crepin VF; Frankel G; Masters SL; Vince J; Murphy JM; Sunde M; Webb AI; Silke J; Hartland EL
    Nat Microbiol; 2017 Jan; 2():16258. PubMed ID: 28085133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lpf gene cluster for long polar fimbriae is not involved in adherence of enteropathogenic Escherichia coli or virulence of Citrobacter rodentium.
    Tatsuno I; Mundy R; Frankel G; Chong Y; Phillips AD; Torres AG; Kaper JB
    Infect Immun; 2006 Jan; 74(1):265-72. PubMed ID: 16368980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. l-Arginine sensing regulates virulence gene expression and disease progression in enteric pathogens.
    Menezes-Garcia Z; Kumar A; Zhu W; Winter SE; Sperandio V
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12387-12393. PubMed ID: 32409599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of coiled-coil peptides on the function of the type III secretion system-dependent activity of enterohemorragic Escherichia coli O157:H7 and Citrobacter rodentium.
    Larzábal M; Zotta E; Ibarra C; Rabinovitz BC; Vilte DA; Mercado EC; Cataldi Á
    Int J Med Microbiol; 2013 Jan; 303(1):9-15. PubMed ID: 23312797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of host cytoskeleton function by the enteropathogenic Escherichia coli and Citrobacter rodentium effector protein EspG.
    Hardwidge PR; Deng W; Vallance BA; Rodriguez-Escudero I; Cid VJ; Molina M; Finlay BB
    Infect Immun; 2005 May; 73(5):2586-94. PubMed ID: 15845460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function.
    Iizumi Y; Sagara H; Kabe Y; Azuma M; Kume K; Ogawa M; Nagai T; Gillespie PG; Sasakawa C; Handa H
    Cell Host Microbe; 2007 Dec; 2(6):383-92. PubMed ID: 18078690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7.
    Gruenheid S; Sekirov I; Thomas NA; Deng W; O'Donnell P; Goode D; Li Y; Frey EA; Brown NF; Metalnikov P; Pawson T; Ashman K; Finlay BB
    Mol Microbiol; 2004 Mar; 51(5):1233-49. PubMed ID: 14982621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pathogen-derived effector modulates host glucose metabolism by arginine GlcNAcylation of HIF-1α protein.
    Xu C; Liu X; Zha H; Fan S; Zhang D; Li S; Xiao W
    PLoS Pathog; 2018 Aug; 14(8):e1007259. PubMed ID: 30125331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation.
    Gao X; Wang X; Pham TH; Feuerbacher LA; Lubos ML; Huang M; Olsen R; Mushegian A; Slawson C; Hardwidge PR
    Cell Host Microbe; 2013 Jan; 13(1):87-99. PubMed ID: 23332158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.